Regulation of G1 cyclin-dependent kinases in the liver: Role of nuclear localization and p27 sequestration

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 277, Issue 6 40-6, 1999, Pages

  Albrecht, Jeffrey H ^a,b   Rieland, Brenda M ^b   Nelsen, Christopher J ^b   Ahonen, Cory L ^b,c  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

^b MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^c Dartmouth College   (United States)

Author keywords

Cyclin dependent kinase activating kinase; Cyclins; Liver regeneration; Nuclear proteins

Indexed keywords

CYCLIN A; CYCLIN D1; CYCLIN D3; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; PROTEIN P130; PROTEIN P27;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; LIVER CELL; LIVER REGENERATION; MALE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RAT; REGULATORY MECHANISM;

EID: 0033379842     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1999.277.6.g1207     Document Type: Article

References (63)

1. Albrecht, J. H., and L. K. Hansen. Cyclin D1 promotes mitogen-independent cell cycle progression in hepatocytes. Cell Growth Differ. 10: 397-404, 1999.
2. Albrecht, J. H., J. S. Hoffman, B. T. Kren, and C. J. Steer. Cyclin and cyclin-dependent kinase 1 mRNA expression in models of regenerating liver and human liver diseases. Am. J. Physiol. 265 (Gastrointest. Liver Physiol. 28): G857-G864, 1993.
3. Albrecht, J. H., M. Y. Hu, and F. B. Cerra. Distinct patterns of cyclin D1 regulation in models of liver regeneration and human liver. Biochem. Biophys. Res. Commun. 209: 648-655, 1995.
4. Albrecht, J. H., R. Y. C. Poon, C. L. Ahonen, B. M. Rieland, C. Deng, and G. S. Crary. Involvement of p21 and p27 in the regulation of Cdk activity and cell cycle progression in the regenerating liver. Oncogene 16: 2141-2150, 1998.
5. 1. Genes Dev. 7: 812-821, 1993.
6. Kipl with cyclin A-Cdk2 and cyclin D2-Cdk4. J. Biol. Chem. 272: 25863-25872, 1997.
7. Castro, A., M. Jaumot, M. Verges, N. Agell, and O. Bachs. Microsomal localization of cyclin A and CDK2 in proliferating rat liver cells. Biochem. Biophys. Res. Commun. 201: 1072-1077, 1994.
8. Kip1 CDK inhibitors are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18: 1571-1583, 1999.
9. Kip1 regulated by mitogen-activated protein kinase (MEK1). Proc. Natl. Acad. Sci. USA 95: 1091-1096, 1998.
10. Cressman, D. E., L. E. Greenbaum, R. A. DeAngelis, G. Ciliberto, E. E. Furth, V. Poli, and R. Taub. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274: 1379-1383, 1996.
11. Dai, K., R. Kobayashi, and D. Beach. Physical interaction of mammalian CDC37 with CDK4. J. Biol. Chem. 271: 22030-22034, 1996.
12. De Luca, A., T. K. MacLachlan. L. Bagella, C. Dean, C. M. Howard, P. P. Claudio, A. Baldi, K. Khalili, and A. Giordano. Aunique domain of pRb2/p130 acts as an inhibitor of Cdk2 kinase activity. J. Biol. Chem. 34: 20971-10974, 1997.
13. Diehl, J. A., M. Cheng, M. F. Roussel, and C. J. Sherr. Glycogen synthase kinase-3b regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12: 3499-3511, 1998.
14. Diehl, J. A., and C. J. Sherr. A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase. Mol. Cell. Biol. 17: 7362-7374, 1997.
15. kip1 in BALB/c 3T3 cells. Mol. Biol. Cell 8: 2081-2092, 1998.
16. Ehrenfried, J. A., T. C. Ko, E. A. Thompson, and B. M. Evers. Cell cycle-mediated regulation of hepatic regeneration. Surgery 122: 927-935, 1997.
17. Fisher, R. P. Reconstitution of mammalian CDK-activating kinase. Methods Enzymol. 283: 256-270, 1997.
18. Garriga, J., A. Limon, X. Mayol, S. G. Rane, J. H. Albrecht, E. P. Reddy, V. Andres, and X. Grana. Differential regulation of the retinoblastoma family of proteins during cell proliferation and differentiation. Biochem. J. 333: 645-654, 1998.
19. Grana, X., J. Garriga, and X. Mayol. Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth. Oncogene 17: 3365-3383, 1998.
20. Grana, X., and E. P. Reddy. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes, and cyclin-dependent kinase inhibitors (CKIs). Oncogene 11: 211-219, 1995.
21. Hauser, P. J., D. Agrawal, B. Chu, and W. J. Pledger. p107 and p130 associated cyclin A has altered substrate specificity. J. Biol. Chem. 272: 22954-22959, 1997.
22. Kato, A., S. Ota, H. Bamba, R. M. Wong, E. Ohmura, Y. Imai, and F. Matsuzaki. Regulation of cyclin D-dependent kinase activity in rat liver regeneration. Biochem. Biophys. Res. Commun. 245: 70-74, 1998.
23. Kato, A., H. Takahashi, Y. Takahashi, and H. Matsushime. Inactivation of the cyclin D-dependent kinase in the rat fibrohlast cell line, 3Y1, induced by contact inhibition. J. Biol. Chem. 272: 8065-8070, 1997.
24. Kato, J. Y., M. Matsuoka, D. K. Strom, and C. J. Sherr. Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase. Mol. Cell. Biol. 14: 2713-2721, 1994.
25. Koff, A., F. Cross, A. Fisher, J. Schumacher, K. Leguellec, M. Philippe, and J. M. Roberts. Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell 66: 1217-1218, 1991.
26. LaBaer, J., M. D. Garrett, L. F. Stevenson, J. M. Slingerland, C. Sandhu, H. S. Chou, A. Fattaey, and E. Harlow. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11: 847-862, 1997.
27. Lamphere, L., F. Fiore, X. Xu, L. Brizuela, S. Keezer, C. Sardet, G. F. Draetta, and J. Gyuris. Interaction between Cdc37 and Cdk4 in human cells. Oncogene 14: 1999-2004, 1997.
28. 1 and S phases of adult rat hepatocytes in vitro. J. Biol. Chem. 271: 11484-11492, 1996.
29. Loyer, P., D. Glaise, S. Cariou, G. Baffet, L. Meijer, and C. Guguen-Guillouzo. Expression and activation of cdks (1 and 2) and cyclins in the cell cycle progression during liver regeneration. J. Biol. Chem. 269: 2491-2500, 1994.
30. Lu, X. P., K. S. Koch, D. J. Lew, V. Dulic, J. Pines, S. I. Reed, T. Hunter, and H. L. Leffert. Induction of cyclin mRNA and cyclin-associated histone H1 kinase during liver regeneration. J. Biol. Chem. 267: 2841-2844, 1992.
31. Mahony, D., D. A. Parry, and E. Lees. Active cdk6 complexes are predominantly nuclear and represent only a minority of the cdk6 in T cells. Oncogene 16: 603-611, 1998.
32. Matsushime, H., D. E. Quelle, S. A. Shurtleff, M. Shibuya, C. J. Sherr, and J. Y. Kato. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14: 2066-2076, 1994.
33. Michalopoulos, G. K., and M. C. De Frances. Liver regeneration. Science 276: 60-66, 1997.
34. Morgan, D. O. Principles of CDK regulation. Nature 374: 131-134, 1995.
35. 1-to-S phase transition. Mol. Cell. Biol. 15: 2612-2624, 1995.
36. Kip1 in anchorage-independent cells. Oncogene 16: 2575-2583, 1998.
37. 1 events and regulation of cell proliferation. Science 246: 603-608, 1989.
38. Pines, J. Cyclins and cyclin-dependent kinases: a biochemical view. Biochem. J. 308: 697-711, 1995.
39. Poon, R. Y. C., W. Jiang, H. Toyoshima, and T. Hunter. Cyclin-dependent kinases are inactivated by a combination of p21 and thr-14/tyr-15 phosphorylation after UV-induced DNA damage. J. Biol. Chem. 271: 13283-13291, 1996.
40. Poon, R. Y. C., H. Toyoshima, and T. Hunter. Redistribution of the CDK inhibitor p27 between different cyclin CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation. Mol. Cell Biol. 6: 1197-1213, 1995.
41. dc2. EMBO J. 12: 3123-3132, 1993.
42. MO15. J. Cell Sci. 107: 2789-2799, 1994.
43. 1--S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. J. Biol. Chem. 272: 10882-10894, 1997.
44. Rinaudo, J. A. S., and S. S. Thorgeirsson. Detection of a tyrosine-phosphorylated form of cyclin A during liver regeneration. Cell Growth Differ. 8: 301-309, 1997.
45. Sclafani, R. A. Cyclin dependent kinase activating kinases. Curr. Opin. Cell Biol. 8: 788-794, 1996.
46. Sewing, A., V. Ronicke, C. Burger, M. Funk, and R. Muller. Alternative splicing of human cyclin E. J. Cell Sci. 107: 581-588, 1994.
47. Sheaff, R. J. Regulation of mammalian cyclin-dependent kinase 2. Methods Enzymol 283: 173-193, 1997.
48. Kip1. Genes Dev. 11: 1464-1478, 1997.
49. 1 phase progression: cycling on cue. Cell 79: 551-555, 1994.
50. Sherr, C. J. Cancer cell cycles. Science 274: 1672-1677, 1996.
51. 1 cyclin-dependent kinases. Genes Dev. 9: 1149-1163, 1995.
52. Soos, T. J., H. Kiyokawa, J. S. Yan, M. S. Rubin, A. Giordano, A. DeBlasio, S. Bottega, B. Wong, H. Mendelsohn, and A. Koff. Formation of p27-CDK complexes during the human mitotic cell cycle. Cell Growth Differ. 7: 135-146, 1996.
53. Steer, C. J. Liver regeneration. FASEB J. 9: 1396-1400, 1995.
54. 1. J. Biol. Chem. 273: 33279-33286, 1998.
55. 1 arrest induced by ultraviolet irradiation. Nature 376: 358-362, 1995.
56. Timchenko, N. A., T. E. Harris, M. Wilde, T. A. Bilyeu, B. L. Burgess-Beusse, M. J. Finegold, and G. J. Darlington. CCAAT/enhancer binding protein a regulates p21 protein and hepatocyte proliferation in newborn mice. Mol. Cell. Biol. 17: 7353-7361, 1997.
57. Trembley, J. H., J. O. Ebbert, B. T. Kren, and C. J. Steer. Differential regulation of cyclin B1 RNA and protein expression during hepatocyte growth in vivo. Cell Growth Differ. 7: 903-916, 1996.
58. Kip1 activates CDC2. J. Biol. Chem. 272: 21669-21672, 1997.
59. Verges, M., A. Castro, M. Jaumot, O. Bachs, and C. Enrich. Cyclin A is present in the endocytic compartment of rat liver cells and increases during liver regeneration. Biochem. Biophys. Res. Commun. 230: 49-53, 1997.
60. Woo, M. S., I. Sanchez, and B. D. Dynlacht. p130 and p107 use a conserved domain to inhibit cellular cyclin-dependent kinase activity. Mol. Cell. Biol. 7: 3566-3579, 1997.
61. Wu, H., M. Wade, L. Krall, J. Grisham, X. Xiong, and T. Van Dyke. Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development, and regeneration. Genes Dev. 10: 245-260, 1996.
62. Yang, S. Q., H. Z. Lin, M. Yin, J. H. Albrecht, and A. M. Diehl. Effects of chronic ethanol consumption on cytokine regulation of liver regeneration. Am. J. Physiol. 275 (Gastrointest. Liver Physiol. 38): G696-G704, 1998.
63. Zhang, H., G. J. Hannon, and D. Beach. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 8: 1750-1758, 1994.